Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2000
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000WO2000032215A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
06/08/2000WO2000032190A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
06/08/2000WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
06/08/2000WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis
06/08/2000WO2000032047A1 Plasmid maintenance system for antigen delivery
06/08/2000WO2000032042A1 Method for the production of mammalian organisms
06/08/2000WO2000032039A1 PURIFIED AND ISOLATED piwi FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME
06/08/2000WO2000018923A3 Slgp protein and nucleic acid molecule and uses therefor
06/08/2000WO2000016089A3 Signal detection techniques for the detection of analytes
06/08/2000WO2000015820A8 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
06/08/2000WO2000015817A3 Stomatin-like genes and their use in plants
06/08/2000WO2000015758A9 Plant resistance to insect pests mediated by viral proteins
06/08/2000WO2000015659A3 Stomach polypeptide zsig28
06/08/2000WO2000014275A3 Two-colour differential display, used as a method for detecting regulated genes
06/08/2000WO2000014200A3 Essential bacterial genes and their use
06/08/2000WO2000012704A9 Enhanced functional expression of g protein-coupled receptors
06/08/2000WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
06/08/2000WO2000011191A3 Tpl-2/cot kinase and methods of use
06/08/2000WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000011138A8 Salt-tolerant transgenic turfgrass
06/08/2000WO2000009755A3 Domain specific gene evolution
06/08/2000WO2000009750A9 Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression
06/08/2000WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
06/08/2000WO2000008212A9 Gel microdrops in genetic analysis
06/08/2000WO2000008191A3 Herpes virus vectors for dendritic cells
06/08/2000WO2000008190A3 Sterol methyltransferase gene
06/08/2000WO2000008175A3 Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
06/08/2000WO2000008142A3 Fibrous proteins and the production thereof
06/08/2000WO2000007629A3 Peg-urate oxidase conjugates and use thereof
06/08/2000WO2000004164A3 Glucosylglycerol phosphate synthase gene for producing the low-molecular protective substance glucosylglycerol and the use thereof
06/08/2000WO2000004137A9 Human aspartic proteases
06/08/2000WO2000003012A3 Expression of eukaryotic peptides in plant plastids
06/08/2000WO2000001842A8 Screening of hydrolase libraries for enantioselective enzymes
06/08/2000WO1999065938A9 Fy7 polymerase
06/08/2000WO1999064572A3 Poly(adp-ribose) polymerase gene
06/08/2000WO1999043803A9 Genomic gene encoding hm1.24 antigen protein and promoter thereof
06/08/2000WO1999013976A9 Apparatuses and methods for isolating nucleic acid
06/08/2000DE19959690A1 Liposome-based DNA transfer agent, useful e.g. in gene therapy, contains an alkylphospholipid and additional amphiphile to improve transmembrane transport
06/08/2000DE19958198A1 Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs) With the IGF-1 receptor interacting proteins (IIPs)
06/08/2000DE19856463A1 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors
06/08/2000DE19855314A1 Verfahren zur fermentiven Herstellung von D-Pantothensäure unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the preparation of fermentiven D-pantothenic acid using strains of the family Enterobacteriaceae
06/08/2000DE19855313A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure durch Verstärkung des panD-Gens in Mikroorganismen A process for the fermentative preparation of D-pantothenic acid by enhancing the panD gene in microorganisms
06/08/2000DE19855312A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure unter Verwendung coryneformer Bakterien A process for the fermentative preparation of D-pantothenic acid using coryneform bacteria
06/08/2000DE19854946A1 Klonieren und Kopieren an Oberflächen Cloning and copying at surfaces
06/08/2000CA2851896A1 Plant diacylglycerol acyltransferases
06/08/2000CA2715086A1 Lipolytic enzyme variants
06/08/2000CA2703147A1 Plant diacylglycerol acyltransferases
06/08/2000CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2353800A1 Gene networks for control of gene expression
06/08/2000CA2353793A1 Length determination of nucleic acid repeat sequences by discontinuous primer extension
06/08/2000CA2353643A1 Methods for producing selected interstrand cross-links in chromosomal nucleic acids and applications thereof
06/08/2000CA2353577A1 Fruit flavour related genes and use thereof
06/08/2000CA2353576A1 Novel nucleic acid transferring agents, compositions containing them and uses
06/08/2000CA2353575A1 Methods for making recombinant cells
06/08/2000CA2353563A1 Development of novel anti-microbial agents based on bacteriophage genomics
06/08/2000CA2353562A1 Method and system for detecting oligonucleotides in a sample
06/08/2000CA2353550A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000CA2353108A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2353103A1 Method for separating nucleic acids into populations
06/08/2000CA2353102A1 Novel tumor antigen protein art-1 and tumor antigen peptide thereof
06/08/2000CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000CA2353087A1 Isolation and characterization of a n. crassa silencing gene and uses thereof
06/08/2000CA2353080A1 Control of flowering
06/08/2000CA2352760A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352568A1 Methods for introducing heterologous cells into fish
06/08/2000CA2352539A1 Recombinant soluble fc receptors
06/08/2000CA2352538A1 Erythropoietic compounds
06/08/2000CA2352532A1 Compositions and methods for increasing bone mineralization
06/08/2000CA2352478A1 Plant 1-deoxy-d-xylulose 5-phosphate synthase
06/08/2000CA2352468A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000CA2352464A1 Methods for transforming plastids
06/08/2000CA2352457A1 Plasmid maintenance system for antigen delivery
06/08/2000CA2351870A1 Scorpion toxins
06/08/2000CA2351731A1 Compositions and methods for regulating bacterial pathogenesis
06/08/2000CA2351671A1 Transgenic circulating endothelial cells
06/08/2000CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family
06/08/2000CA2350592A1 Method for the production of mammalian organisms
06/08/2000CA2350069A1 Methods to reduce variance in treatment studies using genotyping
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2000WO2000039288A1 Polypeptides
06/07/2000EP1006363A2 Biochip and method for producing the same
06/07/2000EP1006200A2 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
06/07/2000EP1006199A1 Applications with and methods for producing selected interstrand crosslinks in nucleic acid
06/07/2000EP1006197A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/07/2000EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein
06/07/2000EP1006195A1 INFECTIOUS VECTORS AND CLONES OF PLANTS DERIVED FROM THE TURNIP MOSAIC VIRUS (TuMV)
06/07/2000EP1006194A2 C-erbB-2 external domain: GP75
06/07/2000EP1006193A2 Method for the fermantative production of D-pantothenic acid using Enterobacteriaceae strains
06/07/2000EP1006192A2 Method for the fermentative production of D- pantothenic acid by amplification of the panD gene of microorganisms
06/07/2000EP1006191A2 DNA encoding toluene monooxygenase, method for degrading chlorinated aliphatic hydrocarbons and aromatic compounds and method for environment remediation